Effect of Oral Administration of Kalyanaka Ghritam in Pediatric Spastic Cerebral Palsy
Phase 2
- Conditions
- Health Condition 1: F82- Specific developmental disorder ofmotor function
- Registration Number
- CTRI/2019/07/020410
- Lead Sponsor
- Ministry of AYUSH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Children suffering from spastic cerebral palsy in the age group of 2- 5 years of age will be selected using GMFCS scoring.
2. Cerebral palsy children with spasticity
Exclusion Criteria
Cerebral palsy with seizure disorders
Spastic cerebral palsy with multiple contractures
Cerebral palsy patients who have undergone selective dorsal rhizotomy
CP patients who are on muscle relaxants such as baclofen,diazepam for the past 1 year
CP with Hydrocephalus requiring surgical intervention
CP Children suffering from acute infections, infectious diseases
CP children with grade 5 spasticity will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method